Psoriasiform and pustular eruption induced by infliximab

被引:44
作者
Takahashi, Hidetoshi
Hashimoto, Yoshio
Ishida-Yamamoto, Akemi
Ashida, Toshifumi
Kohgo, Yutaka
Iizuka, Hajime
机构
[1] Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan
[2] Asahikawa Med Coll, Dept Internal Med, Asahikawa, Hokkaido, Japan
关键词
infliximab; psoriasiform eruption; tumor necrosis factor (TNF)-alpha;
D O I
10.1111/j.1346-8138.2007.00312.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Although antitumor necrosis factor (anti-TNF)-alpha therapy provides beneficial effects on various chronic inflammatory skin diseases including psoriasis, cutaneous side-effects have also been reported. We describe four patients who showed psoriasiform eruption following anti-TNF-alpha therapy (infliximab) for Crohn's disease. In all patients, Crohn's disease had responded well to infliximab. Three patients developed plaque-type psoriasiform eruption on the trunk and four extremities, while one patient showed pustular eruption on the palms and soles accompanied with plaque-type psoriasis. In all these patients, skin lesions subsided with topical application of corticosteroid ointment or psoralen plus ultraviolet A treatment.
引用
收藏
页码:468 / 472
页数:5
相关论文
共 25 条
[1]   Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease? [J].
Baeten, D ;
Kruithof, E ;
Van den Bosch, F ;
Van den Bossche, N ;
Herssens, A ;
Mielants, H ;
De Keyser, F ;
Veys, EM .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (09) :829-834
[2]   Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFα receptors [J].
Berg, L ;
Lampa, J ;
Rogberg, S ;
van Vollenhoven, R ;
Klareskog, L .
ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (02) :133-139
[3]   Skin reaction to adalimumab [J].
Beuthien, W ;
Mellinghoff, HU ;
von Kempis, J .
ARTHRITIS AND RHEUMATISM, 2004, 50 (05) :1690-1692
[4]   Psoriatic lesions induced by antitumour necrosis factor-α treatment:: two cases [J].
Dereure, O ;
Guillot, B ;
Jorgensen, C ;
Cohen, JD ;
Combes, B ;
Guilhou, JJ .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (02) :506-507
[5]  
DEVOS SA, 2003, ARCH DERMATOL, V138, P388
[6]   REPEATED THERAPY WITH MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
ELLIOTT, MJ ;
MAINI, RN ;
FELDMANN, M ;
LONGFOX, A ;
CHARLES, P ;
BIJL, H ;
WOODY, JN .
LANCET, 1994, 344 (8930) :1125-1127
[7]   Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis:: a prospective study [J].
Flendrie, M ;
Vissers, WHPM ;
Creemers, MCW ;
de Jong, EMGJ ;
van de Kerkhof, PCM ;
van Riel, PLCM .
ARTHRITIS RESEARCH & THERAPY, 2005, 7 (03) :R666-R676
[8]   A randomized trial of etanercept as monotherapy for psoriasis [J].
Gottlieb, AB ;
Matheson, RT ;
Lowe, N ;
Krueger, GG ;
Kang, S ;
Goffe, BS ;
Gaspari, AA ;
Ling, M ;
Weinstein, GD ;
Nayak, A ;
Gordon, KB ;
Zitnik, R .
ARCHIVES OF DERMATOLOGY, 2003, 139 (12) :1627-1632
[9]   Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis [J].
Gottlieb, AB ;
Chaudhari, U ;
Mulcahy, LD ;
Li, S ;
Dooley, LT ;
Baker, DG .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 48 (06) :829-835
[10]   Unexpected onset of psoriasis during infliximab treatment: comment on the article by Beuthien et al [J].
Grinblat, B ;
Scheinberg, M .
ARTHRITIS AND RHEUMATISM, 2005, 52 (04) :1333-1334